Victory Capital Management
VYNT

Victory Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Victory Capital Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-134
Closed -$2K – 3498
2020
Q1 		$2K Buy
+134
New +$2.72K ﹤0.01% 3704
2019
Q4 		– Sell
-57
Closed -$1K – 3482
2019
Q3 		$1K Buy
+57
New +$1.11K ﹤0.01% 3739

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Victory Capital Management's VYNT Position: Q2 2020 in Review

Victory Capital Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2020, closing a stake of 134 shares — an estimated $2K sold.

Victory Capital Management first reported a position in VYNT in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 12 funds tracked by Wall St. Rank hold VYNT as of Q2 2020.

  • Victory Capital Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 134 Vyant Bio, Inc. Common Stock shares in Q2 2020, an estimated $2K.
  • Victory Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Vyant Bio, Inc. Common Stock position peaked at $2K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.